VORVor Biopharma Inc.
$19.16-43% 1Y
$19.16
$6.8652 weeks$33.40
The financials
Vor Biopharma Inc. by the numbers
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Operating income | −$48M | −$274M | n/a |
| Net income | −$63M | −$1.57B | n/a |
| Diluted EPS | −$1.16 | −$251.24 | n/a |
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Operating income | −$48M | −$274M | n/a |
| Net income | −$63M | −$1.57B | n/a |
| Diluted EPS | −$1.16 | −$251.24 | n/a |